# OnCo record bromocriptine (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/bromocriptine/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "bromocriptine" ;
  schema:name "Bromocriptine"@en ;
  schema:alternateName "Bromocriptine mesylate"@en, "Parlodel" ;
  schema:description "Bromocriptine was the first pill that could shrink a pituitary tumour. From the 1970s it turned prolactinomas from a surgical disease into one usually controlled with tablets, and it is still used where cabergoline is unavailable or unsuitable."@en ;
  schema:url <https://onco.cc/drugs/bromocriptine/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Bromocriptine> ;
  schema:citation <https://en.wikipedia.org/wiki/Bromocriptine> ;
  onco:status "approved" ;
  onco:tag "subtype-drugs-wave" ;
  onco:modality "Oral ergot dopamine D2 receptor agonist" ;
  onco:approval "US 1978: Hyperprolactinaemia-associated dysfunction including prolactin-secreting adenomas; acromegaly; Parkinson's disease" ;
  onco:related <https://onco.cc/drugs/cabergoline/> ;
  onco:cancers <https://onco.cc/cancers/pituitary-tumours/> ;
  onco:targets <https://onco.cc/targets/drd2/> ;
  onco:companies <https://onco.cc/companies/novartis/> .